LivaNova acquires remaining stake in Caisson Interventional for $72M

LivaNova acquired the remaining stake in Caisson Interventional for $72 million, including milestone payments. LivaNova previously owned a 49% stake in Caisson, which develops a transcatheter mitral valve replacement device.

“We look forward to joining LivaNova to combine our efforts in bringing a superior technology to market.”massdevice.com

• 1 source
• massdevice.comLivaNova buys out Caisson Interventional for $72m - MassDeviceBrad PerrielloMay 3, 2017

Summarized from public sources; check the original articles before acting on it.